blog 240205 statin2

People living with HIV have up to two times the risk for cardiovascular disease and outcomes  such as heart attacks and strokes compared to people without HIV.  A large international study called REPRIEVE, showed that the use of a daily statin (pitavastatin) by people living with HIV, substantially lowered the risk of a major adverse cardiovascular event (heart attack  or stroke) by 35%.

Having a discussion with your HIV specialist about the REPRIEVE study is an important conversation for all people living with HIV to have as soon as possible.

pdf iconHIV and Statins

Aboriginal and Torres Strait Islander Support
housing support for people living with HIV
Ageing Support
Treatments and Managing your HIV